NCT06523413 Effect of Game Activity and Stress Ball on Anxiety and Vital Signs
| NCT ID | NCT06523413 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Suleyman Demirel University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2024-08-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to determine the effect of game activity and stress ball use on preoperative anxiety and vital signs in patients undergoing total knee arthroplasty. The primary purpose of the study is to evaluate the effect of these methods (game activity, stress ball use) on patients' anxiety and vital signs. The research involves three groups: one group will engage in a game activity, another group will use a stress ball, and the control group will receive no intervention. Patients over 18 years of age who pass the Mini-Cog test, demonstrate cognitive competence and meet other sampling criteria will be included in the study. Data will be collected using the State Anxiety Scale, a vital signs and pain level form, and a descriptive characteristics form.
Eligibility Criteria
Inclusion Criteria: Being over 18 years old Undergoing total knee arthroplasty Having passed the Mini-Cog test Ability to understand, read, and write Turkish No hearing or speech problems Having a person accompanying the patient Exclusion Criteria: Not wanting to participate in the research Unstable general condition Sudden change in vital signs Having a psychological disorder and using antidepressant medication Having any psychiatric or cognitive/mental disease (e.g., dementia) Use of psychiatric medication for any reason
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06523413 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06523413 currently recruiting?
Yes, NCT06523413 is actively recruiting participants. Contact the research team at filizsalman@sdu.edu.tr for enrollment information.
Where is the NCT06523413 trial being conducted?
This trial is being conducted at Isparta, Turkey (Türkiye).
Who is sponsoring the NCT06523413 clinical trial?
NCT06523413 is sponsored by Suleyman Demirel University. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.